Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Hiroyasu Misumi is active.

Publication


Featured researches published by Hiroyasu Misumi.


Microbiology and Immunology | 1995

The measurement of swimming velocity of Vibrio cholerae and Pseudomonas aeruginosa using the video tracking method

Mika Shigematsu; Yuko Meno; Hiroyasu Misumi; Kazunobu Amako

The swimming velocities of two monotrichous flagellated bacteria were measured by a computer‐assisted video tracking method. Tracing the moving path of the individual bacterium revealed that the bacterial cell did not swim continuously in a straight direction, but frequently changed swimming direction and velocity. The average swimming velocities calculated from the 3‐sec path were 75.4 ±9.4 μm/sec in four strains of Vibrio cholerae and 513 ±8.4 μm/sec in five strains of Pseudomonas aeruginosa. These results suggest that V. cholerae swim faster than P. aeruginosa at 30 C in nutrient broth. This method is useful for a detailed analysis of bacterial movement and moving patterns in different environmental conditions.


Drugs | 1995

A Comparative Study of Ofloxacin Twice and Three Times Daily in the Treatment of Respiratory Tract Infections

Yoshiro Sawae; Kiyoshi Ninomiya; Koji Takaki; Nobuyuki Shimono; Hiroyasu Misumi; Kaoru Okada

~-Streptococci 2 4 Staphylococcus 6 2 aureus Haemophilus 2 5 influenzae Pseudomonas 2 3 aeruginosa Other 4 5 Normal flora 12 11 a Mean ± standard deviation. Abbreviations: BID = twice daily; TID = three times daily. In Japan, ofloxacin 100 to 200mg three times daily is the usual dosage regimen in the treatment of RTIs, while in Europe 200mg twice daily is the usual regimen, based on its elimination half-life of about 4 hours. We performed a study comparing ofloxacin 200mg twice daily (BID group) vs 200mg three times daily (TID group), in the treatment of RTIs.


Fems Microbiology Letters | 1996

Resuscitation of Vibrio cholerae O1 strain TSI-4 from a viable but nonculturable state by heat shock

Sun Nyunt Wai; Tetsuhiro Moriya; Katsuhiko Kondo; Hiroyasu Misumi; Kazunobu Amako


Japanese Journal of Medicine | 1988

Necrotizing Myelopathy Associated with Hepatocellular Carcinoma

Hiroyasu Misumi; Hiromi Ishibashi; Kazutoshi Kanayama; Wataru Kajiyama; Hideyuki Nomura; Takuya Sugimoto; Kaichiro Hiroshige; Yoshiyuki Niho


Japanese Journal of Chemotherapy | 1996

A dose range study on cefoselis in bacterial pneumonia

Rinzo Soejima; Yoshihito Niki; Niro Okimoto; Osamu Moriya; Hitoshi Nakano; Kenjiro Kikuchi; Akira Saito; Ichiro Nakayama; Masumi Tomizawa; Kazuki Konishi; Kazuo Obara; Masashi Tamura; Akira Watanabe; Hiroshi Takahashi; Shigeo Takizawa; Mikae Nakamura; Kohya Shiba; Osamu Sakai; Kazuhisa Okada; Hiroichi Tanimoto; Tetsuo Okamura; Kaoru Shimada; Yasuyuki Sano; Norihisa Akiyama; Yasuko Tanaka; Takashi Inamatsu; Hiroyuki Kobayashi; Susumu Sakayori; Hiroshi Miura; Jingoro Shimada


Japanese Journal of Chemotherapy | 1994

Bacteriological and clinical studies on tazobactam/piperacillin

Yoshiro Sawae; Kaoru Okada; Koji Takagi; Hiroyasu Misumi; Nobuyuki Shimono; Katsuhiko Eguchi; Yoshiyuki Niho


Nippon Ishinkin Gakkai Zasshi | 1993

Deep-seated Mycoses in Hematopoietic Disorders

Kaoru Okada; Mika Shigematsu; Koji Takaki; Katsuhiko Eguchi; Hiroyasu Misumi; Nobuyuki Shimono; Yoshiro Sawae


Nippon Ishinkin Gakkai Zasshi | 1993

Retrospective Study on Six Cases of Cryptococcal Meningitis

Koji Takaki; Kaoru Okada; Nobuyuki Shimono; Hiroyasu Misumi; Katsuhiko Eguchi; Yoshiro Sawae

Collaboration


Dive into the Hiroyasu Misumi's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge